Healthy clinical trials
Showing 151–200 of 432 active trials. Describe your situation to see which ones you may be eligible for.
- Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
- A Study of LY4515100 in Healthy Participants
- Psilocybin Efficacy With or Without Pimavanserin Pretreatment
- Adversity, Brain and Opioid Use Study
- A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
- Melanin and Dermal Uptake of Thirdhand Cigarette Smoke
- Impact of Heat on Dual Task Performance
- A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants
- A Study of LY4065967 in Healthy Participants
- A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants
- A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
- Acute Pharmacokinetics of Create Wellness Gummies in Healthy Adults
- A Study of LY4302814 in Healthy Participants
- Adaptive Recruitment Curve Analysis Using Bayesian Modeling
- Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
- Testing a Non-Invasive Spinal Stimulation Device
- The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
- Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
- A Study of TopSpin360 Training Device
- Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
- Identifying the Neural Correlates of Mental Simulation in Multi-Step Planning
- Dose-Dependent Effects of Low-Intensity Focused Ultrasound
- A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Optimizing Liver MRI Using Breath-Holding With and Without Oxygen
- Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA Transporter-1
- A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
- Brain Blood Vessel Responses to Changes in Blood Flow
- Effects of GH and Lirglutide on AgRP
- A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser
- Affect-based Impulsivity in Borderline Personality Disorder
- Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy
- Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
- Neuromodulation of Brain and Emotional Responses to Psychological Stress
- Aimmune Longitudinal Collaboration Study
- Pain and Split-belt Motor Learning in Older Adults
- Intermittent Fasting on Body Fat and Quality of Life
- Experiment 3: Mixed vs Blocked; Dashboard Paradigm
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
- Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling
- Physiology of Human Brain Connectivity
- Microbiome Sampling During Endurance Exercise
- Language Control Across Modalities
- Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
- Increasing Lean Protein Intake in Preschool-age Children and Assessing Effects on Cognition and Select Health Outcomes
- Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
- Gut Oxalate Absorption in Calcium Oxalate Stone Disease
- Airway Data Collection With the Entarik Feeding Tube System
- Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)
- Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
- A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.